313 related articles for article (PubMed ID: 9576083)
1. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study.
Knosalla C; Goëau-Brissonnière O; Leflon V; Bruneval P; Eugène M; Pechère JC; Koskas F; Nicolas MH; Leschi JP; Gerota J; Kieffer E
J Vasc Surg; 1998 Apr; 27(4):689-98. PubMed ID: 9576083
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
[TBL] [Abstract][Full Text] [Related]
3. Cryopreserved Allograft in the Management of Native and Prosthetic Aortic Infections.
Masabni K; Weaver MR; Kandagatla P; Shepard AD; Huang J; Al Adas Z; Liang L; Balraj P; Nypaver TJ; Kabbani LS
Ann Vasc Surg; 2019 Apr; 56():1-10. PubMed ID: 30500628
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model.
Schneider F; O'Connor S; Becquemin JP
Ann Vasc Surg; 2008 Nov; 22(6):815-21. PubMed ID: 18835516
[TBL] [Abstract][Full Text] [Related]
5. Results of cryopreserved arterial allograft replacement for thoracic and thoracoabdominal aortic infections.
Couture T; Gaudric J; Davaine JM; Jayet J; Chiche L; Jarraya M; Koskas F
J Vasc Surg; 2021 Feb; 73(2):626-634. PubMed ID: 33485491
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics.
Javerliat I; Goëau-Brissonnière O; Sivadon-Tardy V; Coggia M; Gaillard JL
J Vasc Surg; 2007 Nov; 46(5):1026-31. PubMed ID: 17905555
[TBL] [Abstract][Full Text] [Related]
7. Bacterial resistance of refrigerated and cryopreserved aortic allografts in an experimental virulent infection model.
Litzler PY; Thomas P; Danielou E; Lucq J; Jacques B; Frebourg N; Plissonnier D; Bastit D; Metayer J; Peillon C; Testart J; Watelet J
J Vasc Surg; 1999 Jun; 29(6):1090-6. PubMed ID: 10359943
[TBL] [Abstract][Full Text] [Related]
8. Management of abdominal stent graft infection with cryopreserved aortic allograft.
Weymann A; Ruhparwar A; Karck M
Asian Cardiovasc Thorac Ann; 2016 Nov; 24(9):904. PubMed ID: 24732087
[No Abstract] [Full Text] [Related]
9. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses.
Goëau-Brissonnière OA; Fabre D; Leflon-Guibout V; Di Centa I; Nicolas-Chanoine MH; Coggia M
J Vasc Surg; 2002 Jun; 35(6):1260-3. PubMed ID: 12042739
[TBL] [Abstract][Full Text] [Related]
10. The results of in situ prosthetic replacement for infected aortic grafts.
Young RM; Cherry KJ; Davis PM; Gloviczki P; Bower TC; Panneton JM; Hallett JW
Am J Surg; 1999 Aug; 178(2):136-40. PubMed ID: 10487266
[TBL] [Abstract][Full Text] [Related]
11. Current status of treatment for aortic graft infection: When should cryopreserved allografts be used?
Janko MR; Bose S; Lawrence PF
Semin Vasc Surg; 2019; 32(1-2):81-87. PubMed ID: 31540661
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin-soaked silver polyester versus expanded polytetrafluoro-ethylene grafts for in situ replacement of infected grafts in a porcine randomised controlled trial.
Gao H; Sandermann J; Prag J; Lund L; Lindholt JS
Eur J Vasc Endovasc Surg; 2012 May; 43(5):582-7. PubMed ID: 22421376
[TBL] [Abstract][Full Text] [Related]
13. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
14. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients.
Kieffer E; Gomes D; Chiche L; Fléron MH; Koskas F; Bahnini A
J Vasc Surg; 2004 May; 39(5):1009-17. PubMed ID: 15111853
[TBL] [Abstract][Full Text] [Related]
15. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination.
Schmacht D; Armstrong P; Johnson B; Pierre K; Back M; Honeyman A; Cuthbertson D; Bandyk D
Vasc Endovascular Surg; 2005; 39(5):411-20. PubMed ID: 16193213
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection.
Aboshady I; Raad I; Shah AS; Vela D; Dvorak T; Safi HJ; Buja LM; Khalil KG
J Vasc Surg; 2012 Sep; 56(3):794-801. PubMed ID: 22579134
[TBL] [Abstract][Full Text] [Related]
17. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
18. Eight-year experience with cryopreserved arterial homografts for the in situ reconstruction of abdominal aortic infections.
Bisdas T; Bredt M; Pichlmaier M; Aper T; Wilhelmi M; Bisdas S; Haverich A; Teebken OE
J Vasc Surg; 2010 Aug; 52(2):323-30. PubMed ID: 20570473
[TBL] [Abstract][Full Text] [Related]
19. Cryopreserved arterial allografts in the treatment of prosthetic graft infections.
Gabriel M; Pukacki F; Dzieciuchowicz Ł; Oszkinis G; Checiński P
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):590-6. PubMed ID: 15121108
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms.
Bisdas T; Wilhelmi M; Haverich A; Teebken OE
J Vasc Surg; 2011 May; 53(5):1274-1281.e4. PubMed ID: 21292430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
